Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 24 Apr 2023
Adding mint flavor to e-cigarette liquids increases the amount of vapour particles produced and is linked, according to a recent study published in Respiratory Research.
Read Full NewsThe U.S. Department of Justice said on Thursday it would immediately loosen restrictions on some marijuana products and move quickly to reclassify the drug as less...
Pembrolizumab and nivolumab show favorable response rates with or without consolidation therapy.
Palbociclib slows cancer cell proliferation in patients with HR+/HER2- locally advanced or metastatic breast cancer.
1.
Early detection of breast cancer may be possible with AI-based mammography microcalcification detection and classification.
2.
Study confirms link between breast density, higher breast cancer risk
3.
More pain, more gain? New biopsy technique found to improve prostate cancer detection
4.
Year in Review: Chronic Lymphocytic Leukemia
5.
New Gene Therapy Nears EU Nod for Bladder Cancer
1.
Cancer Memory: A Persistent Threat to Tumor Recurrence and Metastasis
2.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
3.
Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions
4.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
5.
Uncovering New Hope for Follicular Lymphoma Patients
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V
2.
Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
5.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge